ARCHIVES

Gene Variant Associated With 44 Percent Cancer Risk Reduction

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

In Brief: AACR Award Lectures, Announced; Hungerford Honored for Philadelphia Chromosome Discovery

April 20, 1990

Advocates Call For Metrics And Action Plan In NCI’s Redesign of Cooperative Groups

July 8, 2011

In Brief: NCI Recieves Two Proposals For Antineoplaston Trials, None For Children; Stubble Elected To NAS

June 19, 1992

NCI Grants: UT Southwestern, M.D. Anderson Win Lung Cancer SPORE

December 6, 1996

NCI FY94 Budget To Fund 860 Grants, Increase Prevention, Construction Money

December 3, 1993